Arena Capital Advisors’s SCP & CO Healthcare Acquisition Company Class A Common Stock SHAC Stock Holding History

Arena Capital Advisors’s Portfolio SHAC Stock Details SHAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-299,000	Closed	-$2.95M	–	222
2022 Q3	$2.95M	Hold	299,000	–	–	0.9%	40
2022 Q2	$2.94M	Hold	299,000	–	–	0.74%	49
2022 Q1	$2.92M	Hold	299,000	–	–	0.44%	83
2021 Q4	$2.93M	Hold	299,000	–	–	0.27%	120
2021 Q3	$2.91M	Buy	+299,000	New	+$2.89M	0.23%	138

Arena Capital Advisors's SHAC Position: Q4 2022 in Review

Arena Capital Advisors sold out of SCP & CO Healthcare Acquisition Company Class A Common Stock (SHAC) in Q4 2022, closing a stake of 299,000 shares — an estimated $2.95M sold.

Arena Capital Advisors first reported a position in SHAC in Q3 2021 and held it in 5 quarters. The position peaked at $2.95M in Q3 2022. 0 funds tracked by Wall St. Rank hold SHAC as of Q4 2022.

Arena Capital Advisors reported no remaining SCP & CO Healthcare Acquisition Company Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Arena Capital Advisors sold 299,000 SCP & CO Healthcare Acquisition Company Class A Common Stock shares in Q4 2022, an estimated $2.95M.
Arena Capital Advisors first reported a position in SCP & CO Healthcare Acquisition Company Class A Common Stock in Q3 2021 and held it in 5 quarters.
Arena Capital Advisors's SCP & CO Healthcare Acquisition Company Class A Common Stock position peaked at $2.95M in Q3 2022.
0 funds tracked by Wall St. Rank held SCP & CO Healthcare Acquisition Company Class A Common Stock as of Q4 2022.

Based on Arena Capital Advisors's 13F filing for Q4 2022, filed 9 Feb 2023.